NDR White Papers

Levamisole HCl and Zadaxin tested in two mouse models of ALS

Despite the initial cause, all cases of ALS, familial or sporadic, follow a final common pathogenesis. The ability for the body to...

In Ancient Egypt a person’s essence or soul was passed to their descendants, symbolized by Ka. Amyotrophic lateral sclerosis (ALS) has...

Research in our lab has led to a new understanding of the ancient biology that underlies the circle of injury and recovery. New medicines...

Nothing illustrates that change is the essence of life quite like the butterfly. How does this cloudless sulphur caterpillar, eating the...

Cathleen Lutz (Jackson Laboratory) described ALS as a “complex disease and consists of a group of conditions unified by a common theme,...

NDR is approaching ALS from multiple directions- in 2021 we have 17 active projects! What is fascinating is the emerging overlap between...

Immunonormalizing molecules thymopoietin and levamisole HCl Inflammation and regulation of inflammatory responses are necessary for life....

RAN Proteins The discovery of a repeat expansion1 in the C9orf72 gene is important because it is a model to explain central...

NDR’s goals are simple, bring promising therapies to ALS patients and know which treatment is appropriate for a patient by evaluating...

Amyotrophic lateral sclerosis (ALS) is a motor neuron disease of animals and man with life-altering consequences. The defining pathology...